Overview

Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluate the medication vasopressin for its ability to preserve kidney function in patients undergoing liver transplantation.
Phase:
N/A
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
Emory University
Treatments:
Arginine Vasopressin
Vasopressins